Phosphodiesterase (PDE)4 inhibitors: Anti-inflammatory drugs of the future?

Trends in Pharmacological Sciences

Volumn 18, Issue 5, 1997, Pages 164-170

  Teixeira, M M ^a   Gristwood, R W ^b   Cooper, N ^c   Hellewell, P G ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b Stevenage Biosciences Ltd   (United Kingdom)

^c Chiroscience Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 BUTOXY 4 METHOXYBENZYL) 2 IMIDAZOLIDINONE; 4 [2 [3 (CYCLOPENTYLOXY) 4 METHOXYPHENYL] 2 PHENYLETHYL]PYRIDINE; ATIZORAM; BRL 61063; CP 77059; DENBUFYLLINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; LIPOPOLYSACCHARIDE; MNS 949; ORG 20241; PHOSPHODIESTERASE INHIBITOR; PHOSPHODIESTERASE IV; PICLAMILAST; RO 20174; ROLIPRAM; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; ZARDAVERINE;

ADULT RESPIRATORY DISTRESS SYNDROME; ALLERGIC DISEASE; ARTHRITIS; ASTHMA; ENZYME INHIBITION; GLOMERULOSCLEROSIS; INFLAMMATION; INFLAMMATORY CELL; INFLAMMATORY DISEASE; MULTIPLE SCLEROSIS; PARKINSON DISEASE; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; SEPTIC SHOCK; TISSUE INJURY;

EID: 0030984966     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(97)01049-3     Document Type: Review

References (101)

1. Barnes P. J. New Engl. J. Med. 332:1995;868-875.
2. Nicholson C. D., Challiss R. A. J., Shahid M. Trends Pharmacol. Sci. 12:1991;19-27.
3. Nicholson C. D., Shahid M. Pulm. Pharmacol. 7:1994;1-17.
4. Kammer G. M. Immunol. Today. 9:1988;222-229.
5. Beavo J. A., Conti M., Heaslip R. J. Mol. Pharmacol. 46:1994;399-405.
6. Djukanovic R. et al. Am. Rev. Respir. Dis. 142:1990;434-457.
7. Giembycz M. A., Kelly J. J. Costello J. F., Piper P. J. Methylxanthines and Phosphodiesterase Inhibitors in the Treatment of Airways Disease. 1994;27-27 Parthenon Press.
8. Teixeira M. M., Rossi A. G., Williams T. J., Hellewell P. G. Br. J. Pharmacol. 112:1994;332-340.
9. Gozzard N. et al. Br. J. Pharmacol. 118:1996;1201-1208.
10. Howell R. E., Jenkins L. P., Howell D. E. J. Pharmacol. Exp. Ther. 275:1995;703-709.
11. Sommer N. et al. Nat. Med. 1:1995;244-248.
12. Genain C. P. et al. Proc. Natl. Acad. Sci. U. S. A. 92:1995;3601-3605.
13. Jung S. et al. J. Neuroimmunol. 68:1996;1-11.
14. Entman M. L., Smith C. W. Cardiovasc. Res. 28:1994;1301-1311.
15. Brochert G. et al. Mol. Cell. Biochem. 132:1994;57-67.
16. Parratt J. R., Szekeres L. Trends Pharmacol. Sci. 16:1995;351-355.
17. Sekut L. et al. Clin. Exp. Immunol. 100:1995;126-132.
18. Tsuboi Y. et al. J. Clin. Invest. 98:1996;262-270.
19. Hulley P. et al. Eur. J. Neurosci. 7:1995;2431-2440.
20. Pettipher E. R. et al. Br. J. Pharmacol. 117:1996;1530-1534.
21. Prabhakar U. et al. Int. J. Immunopharmacol. 16:1994;805-816.
22. Turner C. R., Esser K. M., Wheeldon E. R. Circ. Shock. 39:1993;237-245.
23. Rabinovici R. et al. Circ. Res. 78:1996;329-336.
24. Turner C. R., Andresen C. J., Smith W. B., Watson J. W. Am. J. Respir. Crit. Care Med. 149:1994;1153-1159.
25. Griswold D. E. et al. Inflammation. 17:1993;333-343.
26. Ortiz J. L., Valles J. M., Marti-Cabrera M., Cortijo J., Morcillo E. J. Naunyn-Schmiedeberg's Arch. Pharmacol. 353:1996;200-206.
27. Kumari M., Cover P. O., Poyser R., Buckingham J. Br. J. Pharmacol. 112:1994;163P.
28. Hadley A. J. et al. Br. J. Pharmacol. 119:1996;463-470.
29. Hughes B. et al. Br. J. Pharmacol. 118:1996;1183-1191.
30. Miotla J. M., Teixeira M. M., Jeffery P. K., Hellewell P. G. Br. J. Pharmacol. 116:1995;5P-5P.
31. Teixeira, M. M. and Hellewell, P. G. Eur. J. Pharmacol. (in press).
32. Kambayashi T. et al. J. Immunol. 155:1995;4909-4916.
33. Jilg S. et al. J. Pharmacol. Exp. Ther. 278:1996;421-431.
34. Pober J. S., Slowik M. R., De Luca L. G., Ritchie A. J. J. Immunol. 150:1993;5114-5123.
35. Morandini R. et al. Am. J. Physiol. 270:1996;H807-H816.
36. Derian C. K., Santulli R. J., Rao P. E., Solomon H. F., Barrett J. A. J. Immunol. 154:1995;308 - 317.
37. Teixeira M. M., Rossi A. G., Giembycz M. A., Hellewell P. G. Br. J. Pharmacol. 118:1996;2099-2106.
38. Cohen J. J. Immunol. Today. 14:1993;126-130.
39. Teixeira M. M., Williams T. J., Hellewell P. G. Trends Pharmacol. Sci. 16:1995;418-423.
40. Hallsworth M. P., Giembycz M. A., Barnes P. J., Lee T. H. Br. J. Pharmacol. 117:1996;79-86.
41. McConkey D. J., Orrenius S., Jondal M. J. Immunol. 145:1990;1227-1230.
42. Lomo J., Blomhoff H. K., Beiske K., Stokke T., Smeland E. B. J. Immunol. 154:1995;1634-1643.
43. Rossi A. G. et al. Biochem. Biophys. Res. Commun. 217:1995;892-899.
44. Zeller E., Stief H. J., Pflug B., Sastre Y., Hernandez M. Pharmacopsychiatry. 59:1988;358-369.
45. Muller T., Engels P., Fozard J. R. Trends Pharmacol. Sci. 17:1996;294-298.
46. Kelly J. J., Barnes P. J., Giembycz M. A. Biochem. J. 318:1996;425-436.
47. Jacobitz S., McLaughlin M. M., Livi G. P., Burman M., Torphy T. J. Mol. Pharmacol. 50:1996;891-899.
48. Duplantier A. J. et al. J. Med. Chem. 39:1996;120-125.
49. Kaplan J. M. et al. Toxicology. 95:1995;186-196.
50. Nelson S., Summer W. R., Jakab G. J. Am. Rev. Respir. Dis. 131:1985;923-927.
51. Parker J. C., Van Volkenburg M. A., Ketchum R. J., Brayman K. L., Andrews K. M. Biochem. Biophys. Res. Commun. 916:1995;923.
52. Chiu N., Park I., Reid I. A. J. Pharmacol. Exp. Ther. 276:1996;1073-1077.
53. Leibowitz M. D. et al. Diabetes. 44:1995;67-74.
54. Klemm P., Harris H. J., Perretti M. Eur. J. Pharmacol. 281:1995;69-74.
55. Alvarez R. et al. J. Pharmacol. Exp. Ther. 48:1995;616-622.
56. Giembycz M. A. Trends Pharmacol. Sci. 17:1996;331-336.
57. Torphy T. J. et al. J. Biol. Chem. 270:1995;23598-23604.
58. Koga S. et al. Am. J. Physiol. 268:1995;C1104-C1113.
59. Nassif E. G., Weinberger M., Thompson R., Huntley W. New Engl. J. Med. 304:1981;71-75.
60. Chan S. C., Reifsnyder D., Beavo J. A., Hanifin J. M. J. Allergy Clin. Immunol. 91:1993;1179-1188.
61. Harbinson P. L. et al. Am. J. Respir. Crit. Care Med. 153:1996;A346-A346.
62. Hanifin J. M. et al. J. Invest. Dermatol. 107:1996;51-56.
63. Giembycz M. A. Biochem. Pharmacol. 43:1992;2041-2051.
64. Simpson P. J., Schelm J. A., Smallwood J. K., Clay M. P., Lindstrom T. D. J. Cardiovasc. Pharmacol. 19:1992;987-995.
65. Nielson C. P., Vestal R. E., Sturm R. J., Heaslip R. J. Allergy Clin. Immunol. 86:1990;801-808.
66. Dent G., Giembycz M. A., Rabe K. F., Barnes P. J. Br. J. Pharmacol. 103:1991;1339-1346.
67. Hatzelmann A., Tenor H., Schudt C. Br. J. Pharmacol. 114:1995;821-831.
68. Souness J. E. et al. Biochem. Pharmacol. 42:1991;937-945.
69. Torphy T. J. et al. Strada S. J., Hidaka H. Advances Second Messenger and Phosphoprotein Research, 1992;289-289 Raven Press.
70. Peachell P. T. et al. J. Immunol. 148:1992;2503-2510.
71. Kleine-Tebbe J. et al. Agents Actions. 36:1992;200-206.
72. Giembycz M. A., Corrigan C. J., Seybold J., Newton R., Barnes P. J. Br. J. Pharmacol. 118:1996.
73. Foissier L., Lonchampt M., Coge F., Canet E. J. Pharmacol. Exp. Ther. 278:1996;1484-1490.
74. Turner N. C., Wood L. J., Burns F. M., Gueremy T., Souness J. E. Br. J. Pharmacol. 108:1993;876-883.
75. Verghese M. W. et al. J. Pharmacol. Exp. Ther. 272:1995;1313-1320.
76. Chini C. C. S., Chini E. N., Williams J. M., Matousovic K., Dousa T. P. Kidney Int. 46:1994;28-36.
77. Matousovic K., Grande J. P., Chini C. C. S., Chini E. N., Dousa T. P. J. Clin. Invest. 96:1995;401-410.
78. Suttorp N., Weber U., Welsch T., Schudt C. J. Clin. Invest. 91:1993;1421-1428.
79. Turner C. R. et al. J. Pharmacol. Exp. Ther. 278:1996;1349-1355.
80. Raeburn D., Karlsson J-A. J. Pharmacol. Exp. Ther. 267:1993;1147-1151.
81. Ortiz J. L., Cortijo J., Valles J. M., Bou J., Morcillo E. J. J. Pharm. Pharmacol. 45:1993;1090-1092.
82. Underwood D. C. et al. J. Pharmacol. Exp. Ther. 266:1993;306-313.
83. Santing R. E., Olymulder C. G., Van der Molen K., Meurs H., Zaagsma J. Eur. J. Pharmacol. 275:1995;75-82.
84. Holbrook M., Gozzard N., James T., Higgs G., Hughes B. Br. J. Pharmacol. 118:1996;1192-1200.
85. Banner K. H. et al. Pulm. Pharmacol. 8:1995;37-42.
86. Underwood D. C. et al. J. Pharmacol. Exp. Ther. 270:1994;250-259.
87. Lagente V., Pruniaux M-P., Junien J-L., Moodley I. Am. J. Respir. Crit. Care Med. 151:1995;1720-1724.
88. Banner K. H., Page C. P. Br. J. Pharmacol. 114:1995;93-98.
89. Lagente V., Moodley I., Perrin S., Mottin G., Junien J-L. Eur. J. Pharmacol. 255:1994;253-256.
90. Raeburn D. et al. Br. J. Pharmacol. 113:1994;1423-1431.
91. Elwood W., Sun J., Barnes P. J., Giembycz M. A., Chung K. F. Inflamm. Res. 44:1995;83-86.
92. Gozzard N. et al. Br. J. Pharmacol. 117:1996;1405-1412.
93. Newsholme S. J., Schwartz L. Inflammation. 17:1993;25-31.
94. Badger A. M., Olivera D. L., Esser K. M. Circ. Shock. 44:1994;188-195.
95. Fischer W., Schudt C., Wendel A. Biochem. Pharmacol. 45:1993;2399-2404.
96. Cardelus I., Gras J., Jauregui J., Llenas J., Palacios J. M. Eur. J. Pharmacol. 299:1996;153-159.
97. Sekut L., Menius J. A., Brackeen M. F., Connolly K. M. J. Lab. Clin. Med. 124:1994;813-820.
98. Begany D. P., Carcillo J. A., Herzer W. A., Mi Z., Jackson E. K. J. Pharmacol. Exp. Ther. 278:1996;37-41.
99. Kips J. C., Joos G. F., Peleman R. A., Pauwels R. A. Clin. Exp. Allergy. 23:1993;518-523.
100. Kato H., Araki T., Itoyama Y., Kogure K. Eur. J. Pharmacol. 272:1995;107-110.
101. Barnard J. W. et al. J. Appl. Physiol. 77:1994;774-781.